International Business Development Opportunities

Apotex is an emerging leader in international markets and is seeking to rapidly broaden its product portfolio through in-licensing and out-licensing in select markets to accelerate its growth.

The following International markets are of interest to Apotex:

• Asia Pacific (APAC): Apotex is a market leader in Australia and New Zealand and rapidly expanding in Southeast Asia.
• Europe, Middle East & Africa (EMEA): Apotex is a leading organization in European countries and rapidly expanding in Middle East-North Africa (MENA).
• Latin- America (LATAM) & Mexico: Apotex has made significant investments in Mexico and is interested in in-licensing finished dosage forms of substitutable generics in CTD format including:
  • Existing Marketing Authorizations
  • Submitted dossiers
  • Opportunities to participate in scheduled DCPs or MRPs
  • Dossiers in late-stage development

Apotex offers the following package of services by Qualified Personnel as the licensee/marketer of your product:

• Sales and marketing to government and private market segments
• Negotiation with pricing and reimbursement authorities, contracts, bids, tenders
• Execution of bioequivalence studies (if repeat studies against local reference product is required)
• Registration and maintenance of Marketing Authorizations
• Pharmacovigilance
• Supply chain logistics – importation, warehousing and distribution
• Packaging – Apotex can take product in either bulk or finished packaged form
• Release testing (if required)